Bayer Acquires Cara Care IBS App | Patients Sue Over GLP-1 Side Effects

Buy The Shift on your local Amazon here: https://geni.us/TheShiftBySuthrum.

Demystifying GI reimbursement challenges (Becker’s GI & Endoscopy)

Navigating the complexities of gastroenterology billing requires a well-thought-out approach to combat challenges like reimbursement cuts and payer restrictions.

Bayer acquires HiDoc Technologies and Cara Care® app for irritable bowel syndrome (Bayer)

Cara Care® is the first prescribed digital health application for the treatment of irritable bowel syndrome (IBS) and offers a novel, holistic therapeutic approach for patients with IBS.

Chapter 19 - Evolution of gastroenterology practice: medicare reform, payment systems, and changing landscape (Science Direct)

This chapter aims to elucidate changes and the forces driving them. It also addresses the role of MSOs, the surge of private equity involvement, and the potential consequences of the recent decision to lower the colon cancer screening age.

How Physicians Can Reclaim Their Negotiating Power With Dr. Eric Bricker (Offcall)

In a conversation with Dr. Graham Walker, Dr. Eric Bricker shares strategies for physicians to negotiate higher salaries and gain greater autonomy, ultimately enhancing patient care.

Billing Mastery: Overcoming Ambulatory Surgery Center (ASC) Financial Challenges (NextServices)

The article explores how ASCs can overcome billing challenges and transform their financial processes into strategic advantages.

Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs (TIME)

GLP-1 drugs like Ozempic and Wegovy have revolutionized diabetes and weight management, but rising reports of severe side effects, including gastroparesis, are sparking lawsuits and calls for deeper research.

Gut microbiota: A consensus paper to regulate the ‘wild west’ of diagnostic tests (Medical Xpress)

A Lancet Gastroenterology & Hepatology consensus outlines guidelines for microbiota testing to curb unsupported DIY kits and promote ethical integration into personalized medicine.

Podcast: SonarMD with Lawrence Kosinski, MD (The Gut Doctor)

In this Innovation series episode, Dr. Parikh interviews Dr. Kosinski, founder of SonarMD, a digital health platform for monthly checks to detect and prevent gut disease flare-ups.

OpenBiome No Longer Distributing FMT For Recurrent C. difficile Infections (GI & Endoscopy News)

OpenBiome, a prominent nonprofit stool bank, has voluntarily suspended the distribution of investigational fecal microbiota transplantation (FMT) preparations for treating recurrent Clostridioides difficile infections (CDI).

Closures, controversies and cyberattacks: The challenges facing gastroenterology leaders (Becker’s GI & Endoscopy)

The gastroenterology field faced significant hurdles in 2024, marked by practice closures, legal disputes, and a growing wave of cyberattacks.

AI for IBD: Will Emerging Technology Revolutionize Care? (Gastroenterology Advisor)

Artificial intelligence (AI) could help revolutionize IBD care, from histopathological assessment to disease monitoring. However, AI for IBD presents challenges as well.

For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the Scope Forward newsletter.

Get the books:

• The Shift: How Digital Innovation is Irreversibly Transforming Gastroenterology and Healthcare
• Scope Forward - The Future of Gastroenterology Is Now In Your Hands.